Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...

Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a ...

MODERNA has won the latest round of its long-running legal battle with Pfizer and its German partner BioNTech over its Covid vaccine. The European Patent Office (EPO) has upheld the validity of one of ...

London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and BioNTech concerning its COVID-19 vaccine. The company has been engaged in ...

The European Patent Office has handed Moderna a victory in its patent dispute with Pfizer and BioNTech regarding its COVID-19 vaccine, according to The Financial Times which first reported the ...

Despite attempts by Pfizer and BioNTech to invalidate the patent, the ruling strengthens Moderna’s position in ongoing global litigation | Pfizer is considering an appeal, while BioNTech remains ...

Shares of vaccine producers’ stocks are trading higher Wednesday on reports indicating disease experts predict a rise in COVID-19 cases. The KP.2 strain represents 28% of infections in the U.S ...

The patents in question are licensed by Pfizer to Puma Biotechnology for the production of the breast-cancer drug Nerlynx. Credit: YES Market Media / Shutterstock.com. The US District Court for the ...